Discover 1,859 paid clinical trials in Virginia. Search by city or condition to find a research study near you that matches your needs across various therapeutic areas.
Virginia provides numerous opportunities for both healthy volunteers and people with specific medical conditions to participate in paid medical research. Major research centers in Richmond, Virginia Beach, and Norfolk are actively seeking participants, offering access to innovative treatments and advanced care.
Filter
1
Filter results
Results: 1,859
A Study to See How Safe and Effective Alirocumab is When Given Weekly to Adult Participants Who Have Hypercholesterolemia
for
Hypercholesterolemia
Location: Wilmington NC, Charlottesville VA, Durham NC,
Sponsor: Regeneron Pharmaceuticals
Sex: All
Age: 18 - 70+
Code: NCT07477704
Phase2, Recruiting
A RCT of Spectacles With Aspherical Lenslets or 0.05% Atropine for Myopia Control
for
Myopia
Location: Boston MA, Philadelphia PA, Norfolk VA, Durham NC,
Sponsor: Jaeb Center for Health Research
Sex: All
Age: 5 - 11
Code: NCT07095894
Phase3, Recruiting
A Study in People With Diabetic Macular Edema to Test How Well Different Doses of BI 3812465 Are Tolerated
for
Diabetic Macular Edema
Location: Waterford CT, Oceanside NY, Falls Church VA,
Sponsor: Boehringer Ingelheim
Sex: All
Age: 18+
Code: NCT07553429
Phase1, Phase2, Recruiting
Xylitol Dental Wipes for the Reduction of Bloodstream Infection Risk in Children With Acute Myeloid Leukemia
Location: Scarborough ME, The Bronx NY, Albany NY,
Sponsor: Children's Oncology Group
Sex: All
Age: 1 - 25
Code: NCT07022678
Phase3, Recruiting
Zilebesiran in Patients With Hypertension Not Adequately Controlled and With Either Established Cardiovascular Disease or High Risk for Cardiovascular Disease
Get alerts for new trials in your area by subscribing now
Combining Immunotherapy and Radiation Therapy to Help Patients Avoid Bladder Removal After Treatment Shrinks Muscle Invasive Bladder Cancer, BRIGHT Trial
for
Muscle Invasive Bladder Urothelial Carcinoma,
Location: Boston MA, Worcester MA, Saint Johnsbury VT, Lebanon NH,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 18+
Code: NCT07061964
Phase2, Recruiting
Global Trial in APG2575 for Patients With CLL/SLL
for
CLL/SLL
Location: Halifax, Boston MA, Greenville NC, Richmond VA,
Sponsor: Ascentage Pharma Group Inc.
Sex: All
Age: 18 - 70+
Code: NCT06104566
Phase3, Recruiting
Comparative Effectiveness of Carvedilol Versus Metoprolol Succinate in Heart Failure Patients With an Implantable Cardioverter Defibrillator
for
Heart Failure With Reduced Ejection Fraction (HFrEF),
Location: Brooklyn NY, Richmond VA, Rochester NY, Detroit MI,
Sponsor: University of Rochester
Sex: All
Age: 18+
Code: NCT06964464
Recruiting
Evaluation of the Fully Closed Loop Omnipod® System in Type 2 Diabetes
for
Type 2 Diabetes Mellitus
Location: Boston MA, New York NY, Newport News VA, Syracuse NY,
Sponsor: Insulet Corporation
Sex: All
Age: 18 - 70+
Code: NCT07521475
Recruiting
A Clinical Study of Calderasib (MK-1084) With Targeted Therapy and Chemotherapy in People With Colorectal Cancer (MK-1084-012/KANDLELIT-012)
for
Colon Adenocarcinoma, Rectal Adenocarcinoma
Location: Moncton, Chicoutimi, New York NY, Hackensack NJ,
Sponsor: Merck Sharp & Dohme LLC
Sex: All
Age: 18+
Code: NCT06997497
Phase3, Recruiting
A Study of Metastases Free Survival With Saruparib vs Placebo Added to a Standard RT/ADT in Men With High-risk Prostate Cancer With a BRCA Mutation
for
Prostate Cancer
Location: Plymouth MA, Providence RI, New York NY, Hackensack NJ,
Sponsor: AstraZeneca
Sex: Male
Age: 18+
Code: NCT06952803
Phase3, Recruiting
The Role of Mobile Apps in Promoting Cardiovascular Health and Motivation to Exercise During Pregnancy
for
Cardiovascular (CV) Risk, Exercise
Location: Norfolk VA
Sponsor: Old Dominion University
Sex: Female
Age: 18 - 45
Code: NCT07166822
Recruiting
ORION-1: Study of AVZO-023 as a Single Agent and in Combination With AVZO-021, and/or Endocrine Therapy in Advanced Solid Tumors
for
HR+/HER2- Breast Cancer, HR+, HER2-, Advanced Breast Cancer
Location: New York NY, Sarasota FL, Houston TX, New Haven CT,
Sponsor: Avenzo Therapeutics, Inc.
Sex: All
Age: 18+
Code: NCT06998407
Phase1, Phase2, Recruiting
AGENT DCB STANCE: Safety and Effectiveness Study of AGENT Drug-Coated Balloon Compared to Standard of Care Percutaneous Coronary Intervention (PCI) Treatment for de Novo Coronary Lesions
for
Coronary Arterial Disease (CAD),
Location: Boston MA, Providence RI, Roslyn NY, The Bronx NY,
Sponsor: Boston Scientific Corporation
Sex: All
Age: 18+
Code: NCT06959524
Recruiting
Study of GS-5319 Given Alone or in Combination in Adults With Solid Tumors
for
Advanced Solid Tumor
Location: Boston MA, Fairfax VA, San Antonio TX
Sponsor: Gilead Sciences
Sex: All
Age: 18+
Code: NCT07128303
Phase1, Recruiting
Safety, Efficacy, and Pharmacokinetics of CSL889 in Adults and Adolescents With Sickle Cell Disease During Vaso-Occlusive Crisis
for
Sickle Cell Disease Vaso-occlusive Crisis
Location: The Bronx NY, New York NY, Baltimore MD, Greenville NC,
Sponsor: CSL Behring
Sex: All
Age: 12+
Code: NCT06699849
Phase2, Recruiting
A Study of Gilteritinib in Adults With Advanced ALK-positive Non-small Cell Lung Cancer (NSCLC)
for
Non-small Cell Lung Cancer (NSCLC),
Location: Hackensack NJ, Fairfax VA, Atlanta GA, Ann Arbor MI,
Sponsor: Astellas Pharma Global Development, Inc.
Sex: All
Age: 18+
Code: NCT07140016
Phase1, Recruiting
Inotuzumab Ozogamicin and Blinatumomab With or Without Ponatinib in Treating Patients With Newly Diagnosed, Recurrent, or Refractory CD22-Positive B-Lineage Acute Lymphoblastic Leukemia
for
B Acute Lymphoblastic Leukemia, Philadelphia Chromosome Negative,
Location: Stony Brook NY, Lake Success NY, Manhasset NY,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 18+
Code: NCT03739814
Phase2, Recruiting
AtraUmatic Laparoscopic HerNia Repair Clinical Investigation to Evaluate the Safety and Performance of The ECLIPSIUM System for Mesh Fixation IDE
for
Hernia
Location: Newport News VA, Wilmington NC, Columbus OH,
Sponsor: Tissium
Sex: All
Age: 22+
Code: NCT07277946
Recruiting
A Study of NEOK002, an EGFR and MUC1 Targeting Bispecific ADC, in Participants With Select Solid Tumors
for
Locally Advanced (Unresectable) or Metastatic Solid Tumors
Location: New York NY, Fairfax VA, Orlando FL, Nashville TN,